Sign Up to like & get
recommendations!
1
Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.01595
Abstract: Objective Targeting immune checkpoints, such as PD-1, represents a promising approach for cancer immunotherapy, achieving long-term disease remission rates in numerous types of cancer. T cell immunoglobulin and ITIM domain (TIGIT) is a checkpoint receptor…
read more here.
Keywords:
cells contributes;
immune escape;
tigit cells;
overexpression tigit ... See more keywords